| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +0.00% | +6.09% | +1.09% | +5.01% | +5.01% | — |
| 14d | 2 | +0.00% | +5.78% | +0.48% | +5.30% | +5.30% | — |
| 30d | 2 | +0.00% | +12.38% | +3.76% | +8.62% | +8.62% | — |
| 60d | 2 | +0.00% | +11.70% | +4.52% | +7.18% | +7.18% | — |
| 90d | 2 | +0.00% | +5.24% | +3.74% | +1.49% | +1.49% | — |
| 180d | 2 | +0.00% | +4.50% | +6.78% | -2.29% | -2.29% | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 2,293 | $15.47 | $35.5K | 213,420 | Jan 14, 2026 | Jan 14, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,856 | — | — | 279,931 | Jan 12, 2026 | Jan 14, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 40,655 | — | — | 254,075 | Jan 12, 2026 | Jan 14, 2026 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 4,542 | $16.99 | $77.2K | 215,713 | Dec 12, 2025 | Dec 12, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 5,502 | — | — | 210,255 | Dec 11, 2025 | Dec 12, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 2,631 | $16.02 | $42.1K | 204,753 | Aug 20, 2025 | Aug 20, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | SALE Chief Financial Officer | 39,082 | $16.16 | $631.6K | 205,299 | Aug 19, 2025 | Aug 20, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,876 | — | — | 25,876 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 38,621 | — | — | 38,621 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 144,677 | — | — | 374,763 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 100,086 | — | — | 200,086 | Mar 3, 2023 | Mar 3, 2023 ↗ | View → |
| ETON ETON PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jul 12, 2022 | Jul 18, 2022 ↗ | View → |